Midland Pharmaceuticals
Midland Pharmaceuticals is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
About Midland Pharmaceuticals
Midland Pharmaceuticals is a startup based in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Midland Pharmaceuticals is a clinical stage pharmaceutical company focused on developing therapeutics for spinal cord injury and stroke. The company is developing MLP-1236, a first-in-class dual inhibitor of MMP-9 and MMP-12 enzymes implicated in the inflammatory process following central nervous system injury.
Explore Midland Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.